Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse

Drug Metabolism and Disposition

Volumn 25, Issue 3, 1997, Pages 371-378

  Sauer, John Michael ^b   Bao, Jingqi ^b   Smith, Richard L ^b   Mcclure, Thomas D ^b   Mayersohn, Michael ^b   Pillai, Usha ^b   Cunningham, Michael L ^b   Sipes, I Glenn ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXANE OXIDE; CYSTEINE; GLUCURONIDE; SULFATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; DRUG ABSORPTION; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; FECES ANALYSIS; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOHEXANES; CYCLOHEXENES; DRUG STABILITY; FEMALE; HYDROGEN-ION CONCENTRATION; INJECTIONS, INTRAVENOUS; MALE; MICE; MICE, INBRED STRAINS; RATS; RATS, INBRED F344;

ANIMALIA;

EID: 0030951785     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. K. C. Leibman and E. Ortiz: Microsomal metabolism of cyclohexene. Hydroxylation in the allylic position. Drug Metab. Dispos. 6, 375-378 (1978).
2. R. E. White, J. T. Groves, and G. A. McClusky: Electronic and steric factors in regioselective hydroxylation catalyzed by purified cytochrome P-450. Acta Biol. Med. German. 38, 475-482 (1979).
3. P. J. van Bladeren, D. D. Breimer, C. J. Seghers, N. P. Vermeulen, and A. C. van der Gen: Dose-dependent stereoselectivity in the formation of mercapturic acids from cyclohexene oxide by the rat. Drug Metab. Dispos. 9, 207-211 (1981).
4. T. M. Guenthner: Selective inhibition and selective induction of multiple microsomal epoxide hydrolases. Biochem. Pharmacol. 35, 839-845 (1986).
5. J. Magdalou and B. D. Hammock: 1,2-Epoxycycloalkanes: substrates and inhibitors of microsomal and cytosolic epoxide hydrolases in mouse liver. Biochem. Pharmacol. 37, 2717-2722 (1988).
6. M. E. Andersen, R. A. Jones, and L. J. Jenkins, Jr.: Enhancement of 1,1-dichloroethylene toxicity by pretreatment of fasted male rats with 2,3-epoxypropan-1-ol. Drug Chem. Toxicol. 1, 63-74 (1977).
7. D. A. Dankovic and R. E. Billings: The role of 4-bromophenol and 4-bromocatechol in bromobenzene covalent binding and toxicity in isolated rat hepatocytes. Toxicol Appl. Pharmacol. 79, 323-331 (1985).
8. O. Perin-Roussel, B. Ekert, F. Zajdela, and P. Jacquignon: Binding of dibenzo(a,e)fluoranthene, a carcinogenic, polycyclic hydrocarbon without K-region, to nucleic acids in a subcellular microsomal system. Cancer Res. 38, 3499-3504 (1978).
9. S. M. Winter and I. G. Sipes: The disposition of acrylic acid in the male Sprague-Dawley rat following oral or topical administration. Food Chem. Toxicol. 31, 615-621 (1993).
10. L. S. Birnbaum, G. M. Decad, and H. B. Matthews: Disposition and excretion of 2,3,7,8-tetrachlorodibenzofuran in the rat. Toxicol. Appl. Pharmacol. 55, 342-352 (1980).
11. H. B. Matthews and M. W. Anderson: The distribution and excretion of 2,4,5,2′,5′-pentachlorobiphenyl in the rat. Drug Metab. Dispos. 3, 211-219 (1975).
12. Scientific Consulting, Inc.: WinNonlin™, Scientific Consulting, Inc., Apex, NC, 1995.
13. H. G. Boxenbaum, S. Riegelman, and R. M. Elashoff: Statistical estimations in pharmacokinetics. J. Pharmacokinet. Biopharmacol. 2, 123-148 (1974).
14. F. C. Lam, C. T. Hung, and D.G. Perrier: Estimation of variance for harmonic mean half-lives. J. Pharmacol. Sci. 74, 229-231 (1985).
15. J. Bao, R. L. Smith, J.-M. Sauer, U. Pillai, and I. G. Sipes: Simultaneous determination of cyclohexene oxide and its metabolites in rat plasma and urine by gas chromatography. J. Chromatogr. B Submitted for publication.
16. D. Guest and J. G. Dent: Effects of epoxide hydratase inhibitors in forward and reversion bacterial mutagenesis assay systems. Environ. Mutagen. 2, 27-34 (1980).
17. S. W. Frantz and J. E. Sinsheimer: Bacterial mutagenicity and toxicity of cycloaliphatic epoxides. Mutat. Res. 90, 67-78 (1981).
18. G. Turchi, S. Bonatti, L. Citti, P. G. Gervasi, and A. Abbondandolo: Alkylating properties and genetic activity of 4-vinylcyclohexene metabolites and structurally related epoxides. Mutat. Res. 83, 419-430 (1981).
19. C. E. Voogd, J. J. van der Stel, and J. J. Jacobs: The mutagenic action of aliphatic epoxides. Mutat. Res. 89, 269-282 (1981).
20. M. A. Pham, J. Magdalou, M. Totis, S. Fournel-Gigleux, G. Siest, and B. D. Hammock: Characterization of distinct forms of cytochromes P-450, epoxide metabolizing enzymes and UDP-glucuronosyltransferases in rat skin. Biochem. Pharmacol. 38, 2187-2194 (1989).
21. D. Parmar and L. T. Burka: Metabolism and disposition of cyclohexanone oxime in male F-344 rats. Drug Metab. Dispos. 19, 1101-1107 (1991).